1
|
Cunha CW, Baker KN, O’Toole D, Cole E, Shringi S, Dewals BG, Vanderplasschen A, Li H. A Vaccine Targeting Ovine Herpesvirus 2 Glycoprotein B Protects against Sheep-Associated Malignant Catarrhal Fever. Vaccines (Basel) 2022; 10:vaccines10122156. [PMID: 36560568 PMCID: PMC9786699 DOI: 10.3390/vaccines10122156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2022] [Revised: 12/06/2022] [Accepted: 12/10/2022] [Indexed: 12/23/2022] Open
Abstract
Malignant catarrhal fever (MCF) is a complex and often fatal disease of ungulates. Effective vaccines are needed to avoid MCF outbreaks and mitigate losses. This study aimed to evaluate a sheep-associated MCF (SA-MCF) vaccine candidate targeting ovine herpesvirus 2 (OvHV-2) glycoprotein B (gB). Rabbits were used as a laboratory animal model to test the safety, immunogenicity, and protective efficacy of a chimeric virus consisting of a recombinant, non-pathogenic strain of alcelaphine herpesvirus-1 encoding OvHV-2 ORF8 to express gB (AlHV-1∆ORF73/OvHV-2-ORF8). Viral-vectored immunizations were performed by using the AlHV-1∆ORF73/OvHV-2-ORF8 chimera alone or as a DNA prime (OvHV-2-ORF8)-virus boost regimen. The viral vector was inoculated by intravenous or intramuscular routes and the DNA was delivered by intradermal shots using a gene gun. The vaccine candidates were deemed safe as no clinical signs were observed following any of the immunizations. Anti-OvHV-2 gB antibodies with neutralizing activity were induced by all immunogens. At three weeks post-final immunization, all animals were challenged intranasally with a lethal dose of OvHV-2. MCF protection rates ranging from 66.7% to 71.4% were observed in vaccinated rabbits, while all mock-vaccinated animals developed the disease. The significant protective efficacy obtained with the vaccine platforms tested in this study encourages further trials in relevant livestock species, such as cattle and bison.
Collapse
Affiliation(s)
- Cristina W. Cunha
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA
- Correspondence: ; Tel.: +1-509-335-6072
| | - Katherine N. Baker
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA
| | - Donal O’Toole
- Department of Veterinary Sciences, University of Wyoming, Laramie, WY 82070, USA
| | - Emily Cole
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA
| | - Smriti Shringi
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA
| | - Benjamin G. Dewals
- Fundamental and Applied Research in Animals and Health (FARAH), Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium
| | - Alain Vanderplasschen
- Fundamental and Applied Research in Animals and Health (FARAH), Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium
| | - Hong Li
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA
| |
Collapse
|
2
|
Russell GC, Percival A, Grant DM, Bartley K, Turnbull D, McLean K, Lienhard J, Bachofen C. Development of a recombinant ELISA for ovine herpesvirus 2, suitable for use in sheep. J Virol Methods 2021; 299:114329. [PMID: 34653445 DOI: 10.1016/j.jviromet.2021.114329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 10/08/2021] [Accepted: 10/10/2021] [Indexed: 11/17/2022]
Abstract
The minor capsid protein of ovine herpesvirus 2, identified as a potential antigen for serological testing, was over-expressed and purified to allow its assessment in ELISA. The corresponding gene sequence (OvHV-2 orf65, Ov65) was modified to incorporate epitope tags and internal restriction enzyme sites in an E. coli codon-optimised version of the gene. This codon-optimised gene was then subject to internal deletions to identify regions of the protein that could be removed while maintaining protein solubility and antigenicity. It was found that a derivative with deletion of the conserved 5'-end of the gene (Ov65delB) expressed a polypeptide that was soluble when over-expressed in bacteria and was detected by OvHV-2 specific sera. Proteomic analysis of the affinity purified Ov65delB showed that it contained multiple predicted Ov65 tryptic peptides but also showed contamination by co-purifying E. coli proteins. An indirect ELISA, based on this affinity-purified OV65delB, was optimised for use with sheep and cattle samples and cut-off values were established based on known negative serum samples. Analysis of groups of samples that were either presumed infected (UK sheep) or tested OvHV-2 positive or negative by PCR (cattle MCF diagnostic samples) showed that the assay had 95 % sensitivity and 96 % specificity for sheep serum; and 80 % sensitivity and 95 % specificity for cattle serum. The lower sensitivity with cattle samples appeared to be due to a lack of serological response in some MCF-affected cattle. This recombinant antigen therefore shows promise as the basis of an inexpensive, simple and reliable test that can be used to detect OvHV-2-specific antibody responses in both MCF-affected animals and in OvHV-2 reservoir hosts.
Collapse
Affiliation(s)
- George C Russell
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK.
| | - Ann Percival
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK
| | - Dawn M Grant
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK
| | - Kathryn Bartley
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK
| | - Dylan Turnbull
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK
| | - Kevin McLean
- Moredun Research Institute, Pentlands Science Park, Midlothian, UK
| | - Julia Lienhard
- Institute of Virology, Vetsuisse Faculty of the University of Zurich, Zürich, Switzerland
| | - Claudia Bachofen
- Institute of Virology, Vetsuisse Faculty of the University of Zurich, Zürich, Switzerland.
| |
Collapse
|
3
|
Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant. Vaccine X 2021; 8:100090. [PMID: 33912826 PMCID: PMC8065228 DOI: 10.1016/j.jvacx.2021.100090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Revised: 03/04/2021] [Accepted: 03/18/2021] [Indexed: 11/24/2022] Open
Abstract
MCF vaccine was tested with and without adjuvant and containing inactivated virus. Adjuvant was required for optimal virus neutralising antibody responses. Storage of AlHV-1 with Emulsigen adjuvant significantly reduced virus viability. Vaccination with adjuvant-inactivated AlHV-1 did not reduce antibody responses.
The experimental vaccine for bovine malignant catarrhal fever consists of viable attenuated alcelaphine herpesvirus 1 (AlHV-1) derived by extensive culture passage, combined with an oil-in-water adjuvant, delivered intramuscularly. This immunisation strategy was over 80% effective in previous experimental and field trials and protection appeared to be associated with induction of virus-neutralising antibodies. Whether the vaccine virus is required to be viable at the point of immunisation and whether adjuvant is required to induce the appropriate immune responses remains unclear. To address these issues two studies were performed, firstly to analyse immune responses in the presence and absence of adjuvant and secondly, to investigate immune responses to vaccines containing adjuvant plus viable or inactivated AlHV-1. The first study showed that viable attenuated AlHV-1 in the absence of adjuvant induced virus-specific antibodies but the titres of virus-neutralising antibodies were significantly lower than those induced by vaccine containing viable virus and adjuvant, suggesting adjuvant was required for optimal responses. In contrast, the second study found that the vaccine containing inactivated (>99.9%) AlHV-1 induced similar levels of virus-neutralising antibody to the equivalent formulation containing viable AlHV-1. Together these studies suggest that the MCF vaccine acts as an antigen depot for induction of immune responses, requiring adjuvant and a suitable antigen source, which need not be viable virus. These observations may help in directing the development of alternative MCF vaccine formulations for distribution in the absence of an extensive cold chain.
Collapse
|
4
|
Shringi S, O’Toole D, Cole E, Baker KN, White SN, Donofrio G, Li H, Cunha CW. OvHV-2 Glycoprotein B Delivered by a Recombinant BoHV-4 Is Immunogenic and Induces Partial Protection against Sheep-Associated Malignant Catarrhal Fever in a Rabbit Model. Vaccines (Basel) 2021; 9:vaccines9020090. [PMID: 33530566 PMCID: PMC7911203 DOI: 10.3390/vaccines9020090] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 01/21/2021] [Accepted: 01/22/2021] [Indexed: 11/16/2022] Open
Abstract
An efficacious vaccine for sheep-associated malignant catarrhal fever (SA-MCF) is important for the livestock industry. Research towards SA-MCF vaccine development is hindered by the absence of culture systems to propagate the causative agent, ovine herpesvirus-2 (OvHV-2), which means its genome cannot be experimentally modified to generate an attenuated vaccine strain. Alternative approaches for vaccine development are needed to deliver OvHV-2 antigens. Bovine herpesvirus 4 (BoHV-4) has been evaluated as a vaccine vector for several viral antigens with promising results. In this study, we genetically engineered BoHV-4 to express OvHV-2 glycoprotein B (gB) and evaluated its efficacy as an SA-MCF vaccine using a rabbit model. The construction of a viable recombinant virus (BoHV-4-AΔTK-OvHV-2-gB) and confirmation of OvHV-2 gB expression were performed in vitro. The immunization of rabbits with BoHV-4-AΔTK-OvHV-2-gB elicited strong humoral responses to OvHV-2 gB, including neutralizing antibodies. Following intra-nasal challenge with a lethal dose of OvHV-2, 42.9% of the OvHV-2 gB vaccinated rabbits were protected against SA-MCF, while all rabbits in the mock-vaccinated group succumbed to SA-MCF. Overall, OvHV-2 gB delivered by the recombinant BoHV-4 was immunogenic and partly protective against SA-MCF in rabbits. These are promising results towards an SA-MCF vaccine; however, improvements are needed to increase protection rates.
Collapse
Affiliation(s)
- Smriti Shringi
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA; (S.S.); (E.C.); (K.N.B.); (S.N.W.)
| | - Donal O’Toole
- Department of Veterinary Sciences, University of Wyoming, Laramie, WY 82070, USA;
| | - Emily Cole
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA; (S.S.); (E.C.); (K.N.B.); (S.N.W.)
| | - Katherine N. Baker
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA; (S.S.); (E.C.); (K.N.B.); (S.N.W.)
| | - Stephen N. White
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA; (S.S.); (E.C.); (K.N.B.); (S.N.W.)
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA;
- Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA
| | - Gaetano Donofrio
- Department of Medical-Veterinary Science, University of Parma, 43126 Parma, Italy;
- Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA 99164, USA
| | - Hong Li
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA;
| | - Cristina W. Cunha
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA; (S.S.); (E.C.); (K.N.B.); (S.N.W.)
- Animal Disease Research Unit, Agricultural Research Service, USDA, Pullman, WA 99164, USA;
- Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA 99164, USA
- Correspondence:
| |
Collapse
|
5
|
Cunha CW, O’Toole D, Taus NS, Shringi S, Knowles DP, Li H. A Rabbit Model for Sheep-Associated Malignant Catarrhal Fever Research: from Virus Infection to Pathogenesis Studies and Vaccine Development. CURRENT CLINICAL MICROBIOLOGY REPORTS 2019. [DOI: 10.1007/s40588-019-00126-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
6
|
Alhajri SM, Cunha CW, Knowles DP, Li H, Taus NS. Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay. PLoS One 2018; 13:e0200130. [PMID: 29966004 PMCID: PMC6028116 DOI: 10.1371/journal.pone.0200130] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 06/20/2018] [Indexed: 01/16/2023] Open
Abstract
Gammaherpesviruses in the genus Macavirus establish clinically unapparent persistent infections in reservoir species. Transmission of some of these viruses, including alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2), to clinically susceptible species in the order Artiodactyla can result in malignant catarrhal fever (MCF), a usually fatal lymphoproliferative disease. Serology can be used to identify MCF virus (MCFV)-infected carrier animals. However, all current serological assays utilize AlHV-1 antigens, thus none is specific for OvHV-2. In situations where sheep and other MCFV carriers are present, such as in zoos and game farms, an OvHV-2-specific assay would determine if OvHV-2 is present in the population. In this study, a recombinant protein containing a truncated OvHV-2 Ov8 glycoprotein was expressed and evaluated as a suitable target antigen to specifically detect OvHV-2 infection using an enzyme linked immunosorbent assay (ELISA). A competitive inhibition (CI)-ELISA that detects an epitope conserved among all MCFVs was used to categorize, as positive or negative, sera from 205 domestic sheep. The Ov8 assay showed 100% diagnostic sensitivity, 98.97% diagnostic specificity, 99.07% positive predictive value, and 100% negative predictive value and very high agreement (kappa = 0.990 and 95% CI = 0.971–1.000) with the CI-ELISA. Sera from animals infected with MCFVs other than OvHV-2 did not cross-react with Ov8 (100% negative predictive value). These data support the use of the Ov8 ELISA as an OvHV-2-specific diagnostic assay.
Collapse
Affiliation(s)
- Salim M. Alhajri
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America
| | - Cristina W. Cunha
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
- Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, United States of America
| | - Donald P. Knowles
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
| | - Hong Li
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
| | - Naomi S. Taus
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, Washington, United States of America
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
- * E-mail:
| |
Collapse
|
7
|
Ovine Herpesvirus 2 Glycoproteins B, H, and L Are Sufficient for, and Viral Glycoprotein Ov8 Can Enhance, Cell-Cell Membrane Fusion. J Virol 2017; 91:JVI.02454-16. [PMID: 28053110 PMCID: PMC5331822 DOI: 10.1128/jvi.02454-16] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Accepted: 12/26/2016] [Indexed: 12/15/2022] Open
Abstract
Ovine herpesvirus 2 (OvHV-2) is a gammaherpesvirus in the genus Macavirus that is carried asymptomatically by sheep. Infection of poorly adapted animals with OvHV-2 results in sheep-associated malignant catarrhal fever, a fatal disease characterized by lymphoproliferation and vasculitis. There is no treatment or vaccine for the disease and no cell culture system to propagate the virus. The lack of cell culture has hindered studies of OvHV-2 biology, including its entry mechanism. As an alternative method to study OvHV-2 glycoproteins responsible for membrane fusion as a part of the entry mechanism, we developed a virus-free cell-to-cell membrane fusion assay to identify the minimum required OvHV-2 glycoproteins to induce membrane fusion. OvHV-2 glycoproteins B, H, and L (gB, gH, and gL) were able to induce membrane fusion together but not when expressed individually. Additionally, open reading frame Ov8, unique to OvHV-2, was found to encode a transmembrane glycoprotein that can significantly enhance membrane fusion. Thus, OvHV-2 gB, gH, and gL are sufficient to induce membrane fusion, while glycoprotein Ov8 plays an enhancing role by an unknown mechanism.IMPORTANCE Herpesviruses enter cells via attachment of the virion to the cellular surface and fusion of the viral envelope with cellular membranes. Virus-cell membrane fusion is an important step for a successful viral infection. Elucidating the roles of viral glycoproteins responsible for membrane fusion is critical toward understanding viral entry. Entry of ovine herpesvirus 2 (OvHV-2), the causative agent of sheep associated-malignant catarrhal fever, which is one of the leading causes of death in bison and other ungulates, has not been well studied due to the lack of a cell culture system to propagate the virus. The identification of OvHV-2 glycoproteins that mediate membrane fusion may help identify viral and/or cellular factors involved in OvHV-2 cell tropism and will advance investigation of cellular factors necessary for virus-cell membrane fusion. We found that OvHV-2 glycoproteins B, H, and L are sufficient for, and viral glycoprotein Ov8 can significantly enhance, cell-cell membrane fusion.
Collapse
|
8
|
Replacement of Glycoprotein B in Alcelaphine Herpesvirus 1 by Its Ovine Herpesvirus 2 Homolog : Implications in Vaccine Development for Sheep-Associated Malignant Catarrhal Fever. mSphere 2016; 1:mSphere00108-16. [PMID: 27504498 PMCID: PMC4973634 DOI: 10.1128/msphere.00108-16] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Vaccine development is a top priority in malignant catarrhal fever (MCF) research. In the case of sheep-associated MCF (SA-MCF) caused by ovine herpesvirus 2 (OvHV-2), progress toward this objective has been hindered by the absence of methods to attenuate or modify the virus, since it cannot be propagated in vitro. As an alternative for vaccine development, in this study, we tested the hypothesis that one of the SA-MCF vaccine candidate targets, OvHV-2 glycoprotein B (gB), could be expressed by a nonpathogenic alcelaphine herpesvirus 1 (AlHV-1) and then evaluated the potential of the AlHV-1/OvHV-2 chimera to be used as a vaccine and a diagnostic tool. The construction and characterization of an AlHV-1/OvHV-2 chimeric virus that is nonpathogenic and expresses an OvHV-2 vaccine target are significant steps toward the development of an SA-MCF vaccine and also provide a valuable means to study OvHV-2 biology.
Collapse
|
9
|
Taus NS, Cunha CW, Marquard J, O’Toole D, Li H. Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses. PLoS One 2015; 10:e0145073. [PMID: 26658281 PMCID: PMC4681746 DOI: 10.1371/journal.pone.0145073] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2015] [Accepted: 11/29/2015] [Indexed: 11/19/2022] Open
Abstract
Some members of the gamma herpesvirus genus Macavirus are maintained in nature as subclinical infections in well-adapted ungulate hosts. Transmission of these viruses to poorly adapted hosts, such as American bison and cattle, can result in the frequently fatal disease malignant catarrhal fever (MCF). Based on phylogenetic analysis, the MCF viruses (MCFV) cluster into two subgroups corresponding to the reservoir hosts' subfamilies: Alcelaphinae/Hippotraginae and Caprinae. Antibody cross-reactivity among MCFVs has been demonstrated using techniques such as enzyme linked immunosorbent and immunofluorescence assays. However, minimal information is available as to whether virus neutralizing antibodies generated against one MCFV cross react with other members of the genus. This study tested the neutralizing activity of serum and plasma from select MCFV-infected reservoir hosts against alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2). Neutralizing antibody activity against AlHV-1 was detected in samples from infected hosts in the Alcelaphinae and Hippotraginae subfamilies, but not from hosts in the Caprinae subfamily. OvHV-2 neutralizing activity was demonstrated in samples from goats (Caprinae) but not from wildebeest (Alcelaphinae). These results show that neutralizing antibody cross reactivity is present to MCFVs within a virus subgroup but not between subgroups. This information is important for diagnosing infection with MCFVs and in the development of vaccines against MCF.
Collapse
Affiliation(s)
- Naomi S. Taus
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America
- * E-mail:
| | - Cristina W. Cunha
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America
| | - Jana Marquard
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America
| | - Donal O’Toole
- Wyoming State Veterinary Laboratory, University of Wyoming, Laramie, Wyoming, United States of America
| | - Hong Li
- Animal Disease Research Unit, Agricultural Research Service, United States Department of Agriculture, Pullman, Washington, United States of America
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America
| |
Collapse
|
10
|
Dry I, Todd H, Deane D, Percival A, Mclean K, Inglis NF, Manson EDT, Haig DM, Nayuni S, Hutt-Fletcher LM, Grant DM, Bartley K, Stewart JP, Russell GC. Alcelaphine herpesvirus 1 glycoprotein B: recombinant expression and antibody recognition. Arch Virol 2015; 161:613-9. [PMID: 26650040 DOI: 10.1007/s00705-015-2701-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2015] [Accepted: 11/22/2015] [Indexed: 11/26/2022]
Abstract
The gammaherpesvirus alcelaphine herpesvirus 1 (AlHV-1) causes fatal malignant catarrhal fever (MCF) in susceptible species including cattle, but infects its reservoir host, wildebeest, without causing disease. Pathology in cattle may be influenced by virus-host cell interactions mediated by the virus glycoproteins. Cloning and expression of a haemagglutinin-tagged version of the AlHV-1 glycoprotein B (gB) was used to demonstrate that the AlHV-1-specific monoclonal antibody 12B5 recognised gB and that gB was the main component of the gp115 complex of AlHV-1, a glycoprotein complex of five components identified on the surface of AlHV-1 by immunoprecipitation and radiolabelling. Analysis of AlHV-1 virus particles showed that the native form of gB was detected by mAb 12B5 as a band of about 70 kDa, whilst recombinant gB expressed by transfected HEK293T cells appeared to be subject to additional cleavage and incomplete post-translational processing. Antibody 12B5 recognised an epitope on the N-terminal furin-cleaved fragment of gB on AlHV-1 virus particles. It could be used to detect recombinant and virus-expressed gB on western blots and on the surface of infected cells by flow cytometry, whilst recombinant gB was detected on the surface of transfected cells by immunofluorescence. Recombinant gB has potential as an antigen for ELISA detection of MCF virus infection and as a candidate vaccine antigen.
Collapse
Affiliation(s)
- Inga Dry
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
- The Roslin Institute, University of Edinburgh, Midlothian, EH25 9RG, UK
| | - Helen Todd
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - David Deane
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - Ann Percival
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - Kevin Mclean
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - Neil F Inglis
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - Erin D T Manson
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - David M Haig
- School of Veterinary Medicine and Science, Nottingham University, Sutton Bonnington, Leicestershire, LE12 5RD, UK
| | - Shilpa Nayuni
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
- Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London, NW3 2PF, UK
| | | | - Dawn M Grant
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - Kathryn Bartley
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK
| | - James P Stewart
- Department of Infection Biology, University of Liverpool, Liverpool, L3 5RF, UK
| | - George C Russell
- Moredun Research Institute, Pentlands Science Park, Midlothian, EH26 0PZ, UK.
| |
Collapse
|